← Leaderboards
Seema Nandi
Selsym Biotech, Inc.
$742,853
Attributed
$742,853
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $488K · FY2021–22$500K$375K$250K$125K$0
'21
'22
Funding mix
By agency
NIH$742,853 · 3
By mechanism
R41$742,853 · 3
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Mission”
- Kelly K Wismer · Department Of Defense$358,750,224
- Valerie Koch · University Corporation For Atmospheric Res$265,601,376
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- John E West · University Of Texas At Austin$131,399,667
- Paul F Gallagher · Woods Hole Oceanographic Institution$92,619,872
- Lisa Garcia Bedolla · University Of California-Berkeley$82,631,880
Research focus
MissionResponseHealingIn VivoMorphologyPublic HealthFibrinFibrin ReceptorInjuryIn VitroCoupledDiabetes MellitusParticlePreclinical DevelopmentAffinityCell Surface ReceptorsAreaBlood PlateletsImmunologicsInfectionCoagulation ProcessInnovationBindingRodent Model
Grant awards (3)
Increasing efficiency of sdFv production in a tobacco-based system for synthetic platelet design$258,501
R41 · FY2022 · HL · contact PI
SymHeal: A novel therapy for treating non-healing diabetic ulcers$229,474
R41 · FY2022 · DK · contact PI
Evaluation of stability and safety of platelet-like particles for treating bleeding after trauma$254,878
R41 · FY2021 · HL · contact PI